— ImmunoGen Inc. (NASDAQ: IMGN) reported its fourth-quarter 2019 earnings of $0.03 per share vs $0.05 per share loss expected.
— Revenue jumped threefold to $44.8 million, versus $29.3 million expected. The results were helped by higher license fees and lower operating expenses.
— For fiscal 2020, company expects revenues between $60 million and $65 million. Operating expenses are projected to be between $165 million and $170 million.
— IMGN shares shot up 5.4% immediately following the announcement.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Earnings Preview: Costco (COST) looks poised to end fiscal 2024 on a high note
Costco Wholesale Corporation (NASDAQ: COST), which operates a chain of membership warehouses, will unveil its fourth-quarter results on the evening of September 26. It has a good track record of
Key takeaways from General Mills’ (GIS) Q1 2025 earnings report
Shares of General Mills, Inc. (NYSE: GIS) gained over 1% on Wednesday after the company’s announcement of its first quarter 2025 earnings results. Revenue came in line with estimates while
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Comments
Comments are closed.